Cytokinetics should hear back from the FDA ... The ISPE Singapore Affiliate Conference & Exhibition is one of the largest and most respected events for bio & pharmaceutical manufacturing ...

Merida Biosciences has emerged from Third Rock Ventures with $121 million in first-round financing for a pipeline of drugs ...

SOUTH SAN FRANCISCO, Calif., April 17, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on April 15, 2025 it granted stock options to purchase an aggregate of 60 ...

SOUTH SAN FRANCISCO, Calif., April 17, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on April 15, 2025 it granted stock options to purchase an aggregate ...

Cytokinetics, Incorporated SOUTH SAN FRANCISCO, Calif., April 17, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on April 15, 2025 it granted stock options ...

We recently made the effort to get to Sarasota to view the Embracing Our Differences art exhibit. We’re always glad we did, and this year even more so! We’re constantly amazed at the ...

He is one of 17 exhibitors whose work is on display in the Due West exhibit now under way at the Montego Bay Cultural Centre in St James. During Sunday’s official opening, Dadag spoke candidly ...

Schedules for Target, Costco, Trader Joe’s and more Afghan, modern California cuisine meet at new Oakland restaurant Jaji A new exhibit running until late 2027 at the Lawrence Hall of Science ...

This idea is one that Recology King County’s Artists in Residence Program has put into practice with the exhibit “The Unbearable Lightness of 300 Tons a Day,” now showing at the North ...

If true, that could spell trouble for Cytokinetics, which is testing its own drug aficamten in nHCM. Aficamten uses the same mechanism of action as Camzyos, meaning that there’s a chance BMS ...

This development is a positive for competitor Cytokinetics, which is developing a similar drug called aficamten for both oHCM and nHCM, said Mizuho analyst Salim Syed. Aficamten is under review ...